Pain Therapeutics, Inc. Stock price Nasdaq
Equities
US69562K5065
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 300M | Capitalization | 883M |
---|---|---|---|---|---|
Net income 2024 * | -92M | Net income 2025 * | 120M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.94 x |
P/E ratio 2024 * |
-10.2
x | P/E ratio 2025 * |
12.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.82% |
Managers | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Eric J. Schoen
DFI | Director of Finance/CFO | 55 | 18-09-30 |
James W. Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Robert Z. Gussin
BRD | Director/Board Member | 86 | 03-02-28 |
Director/Board Member | 76 | 07-12-06 |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.69% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |